# Effect of High-flow Nasal Oxygen on Extubation Outcome

Study · id `cardio:ct-nct02290548` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02290548](<https://clinicaltrials.gov/study/NCT02290548>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02290548

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02290548. Randomized; double masking; primary purpose treatment. Start 2014-12 (registry gives no type); primary completion 2016-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02290548, source copy `cardio:ctgov-nct02290548-2014-12-15`, retrieved 2026-10-26)
- Start date: 2014-12 (registry gives no type) (ClinicalTrials.gov record NCT02290548, source copy `cardio:ctgov-nct02290548-2014-12-15`, retrieved 2026-10-26)
- Primary completion: 2016-09 (anticipated) (ClinicalTrials.gov record NCT02290548, source copy `cardio:ctgov-nct02290548-2014-12-15`, retrieved 2026-10-26)
- Completion: 2016-10 (anticipated) (ClinicalTrials.gov record NCT02290548, source copy `cardio:ctgov-nct02290548-2014-12-15`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02290548, source copy `cardio:ctgov-nct02290548-2014-12-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02290548-2014-12-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of High-flow Nasal Oxygen on Extubation Outcome
- Condition: Respiratory Failure
- Condition: Congestive Heart Failure
- Condition: COPD
- Intervention (Device): high flow nasal cannula
- Lead sponsor: Mackay Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Mackay Memorial Hospital (`cardio:org-mackay-memorial-hospital`)

## Provenance

Content hash: dc164a52d204c897f31a0c0aead4470b6070ecc69245ef9873fa8252ee3be6c8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
